TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8+ T cell priming
TLR5 激动剂与抗 PD-1 治疗联合使用可通过 M1/M2 巨噬细胞极化转变和 CD8+ T 细胞启动增强抗肿瘤作用
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-024-03679-5
Junseok Lee, Keon-Il Im, Sojin Gil, Hyemin Na, Gi-June Min, Nayoun Kim, Seok-Goo Cho
